Please assess the completion status of the following clinical trial:

Trial Title: Vaccine Prevention of Rabies Adopts 4-shot Immunization Method

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* The age is 10-60 years old;~* Underarm temperature ≤ 37.0 ℃.~Exclusion Criteria:~* Have a history of rabies vaccine immunization or use of rabies virus passive immunization agents；~* Has been diagnosed with congenital or acquired immunodeficiency disease；~* Pregnancy (including positive urine pregnancy test) or lactation, planned pregnancy preparation within 2 months.

- Gender: ALL
- Minimum Age: 10 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- Experimental 4 doses (Type: EXPERIMENTAL): Inoculate experimental vaccine according to 2-1-1 immunization procedure
- Experimental 5 doses (Type: EXPERIMENTAL): Inoculate experimental vaccine according to 1-1-1-1-1 immunization procedure
- SPEEDA® 4 doses (Type: ACTIVE_COMPARATOR): Inoculate SPEEDA® according to 2-1-1 immunization procedure

Based on this trial design, predict the completion outcome and termination type (if applicable).